Announcements Trials
Browse Landscape

Status

Completed 7Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 3

Study Type

Interventional 337Observational 7

Sponsor

Cancer Type

Genitourinary 3NET 2Endocrine 2Breast 2Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 3Neuroendocrine Tumors 2Breast Neoplasms 2Neoplastic Cells, Circulating 1Carcinoma, Hepatocellular 1Adenoma, Islet Cell 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Completed × Observational × Everolimus × Clear all
NCT02184416 2026-02-27

ADONIS

Pfizer

Completed
554 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02264665 2023-11-13

OPALINE

Pfizer

Completed
144 enrolled 26 charts

Adenoma, Islet Cell

NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

NCT02809404 2017-10-16

SPOT

Radboud University Medical Center

Completed
75 enrolled
BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell

NCT01390519 2016-01-13

OSAT

Novartis

Completed
30 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02023359 2015-12-29

Danish Observational Study of Everolimus Plus Exemestane in Hormone Receptor (HR) Positive, Human Epidermal Growth Factor 2 (HER2) - Metastatic Breast Cancer

Novartis

Completed
7 enrolled
Breast

Breast Neoplasms

NCT01338090 2012-04-03

NETPET

University Medical Center Groningen

Completed
14 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡